PARP & DDR Inhibitors Summit 2020

PARP & DDR Inhibitors Summit is organized by Hanson Wade and will be held from Jan 28 - 30, 2020 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America.

Description:
PARP and novel DNA Damage Response (DDR) inhibitors are showing great potential in broader tumor indications as they advance through the clinic. This industry-focused summit will equip you with the tools to optimize PARP inhibitors for expanded indications; create best-in-class therapeutics; over-ride resistance and identify novel DDR and synthetic lethal pathways to exploit cancer survival mechanisms.

• Leverage drug and therapeutic combinations with lessons learnt from PARP in the clinic
• Devise personalized treatment plans by examining genotypes and discuss biomarker strategy
• Equip your DDR inhibitors for use in expanded indications
• Inform therapeutic combination selection to overcome acquired resistance
• Analyze the emerging DDR therapeutic landscape and unpick the complex DDR network

The PARP & DDR Inhibitors Summit 2020 gathers the VPs, Heads and Directors of Translational Oncology, Target Discovery, and Early Drug Development. This meeting is the perfect opportunity to gain cutting-edge insights from industry leaders on PARP inhibitor development, creating best-in-class therapeutics, over-riding resistance and identifying novel synthetic lethal pathways to exploit cancer survival mechanisms.

Step out of the office and into a meeting tailored to your niche. Round table talks, panel discussion and networking provide a unique opportunity for open conversation with industry leaders to accelerate your DDR success.

Additional details will be posted as soon as information is available.